Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Feb 6;26(3):1364.
doi: 10.3390/ijms26031364.

Atherosclerosis: A Comprehensive Review of Molecular Factors and Mechanisms

Affiliations
Review

Atherosclerosis: A Comprehensive Review of Molecular Factors and Mechanisms

Vasiliki Tasouli-Drakou et al. Int J Mol Sci. .

Abstract

Atherosclerosis, a condition characterized by the accumulation of lipids and a culprit behind cardiovascular events, has long been studied. However, in recent years, there has been an increase in interest in its initiation, with researchers shifting focus from traditional pathways involving the vascular infiltration of oxidized lipids and towards the novel presence of chronic inflammatory pathways. The accumulation of pro-inflammatory cytokines, in combination with the activation of transcription factors, creates a positive feedback loop that drives the creation and progression of atherosclerosis. From the upregulation of the nod-like receptor protein 3 (NLRP3) inflammasome and the Notch and Wnt pathways to the increased expression of VEGF-A and the downregulation of connexins Cx32, Cx37, and Cx40, these processes contribute further to endothelial dysfunction and plaque formation. Herein, we aim to provide insight into the molecular pathways and mechanisms implicated in the initiation and progression of atherosclerotic plaques, and to review the risk factors associated with their development.

Keywords: atherosclerosis; cardiovascular health; inflammation.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Figure showing the creation of the NLRP3 inflammasome and pro-inflammatory cytokines IL-1β and IL-18. The attachment of oxLDL on the CD36–TLR4–TLR6 signaling complex activates NF-κB, which translocates to the nucleus and binds to NF-κB-dependent promoters for the activation of target genes. The produced NLRP3 binds with an apoptosis-associated speck-like protein (ASC) and procaspase-1 to create an NLRP3 inflammasome. The NLRP3 inflammasome cleaves pro-caspase-1 into its active form caspase-1, which in turn cleaves pro-IL-1β and pro-IL-18 to their active isomers IL-1β and IL-18, respectively. It is important to note that the created IL-1β can bind to IL-1R on the extracellular surface of macrophages to further induce the formation of more IL-1β and IL-18, thus creating a pro-inflammatory environment [27].
Figure 2
Figure 2
Figure summarizing the pathophysiology of atherosclerosis. From the infiltration of LDLs to the creation of a calcified fibrous cap and its rupture, multiple factors contribute to the initiation and progression of atherosclerosis.
Figure 3
Figure 3
Intracellular portion of the Notch pathway. Once the intracellular domain of the Notch receptor (NICD) has been cleaved by the enzyme γ-secretase, it translocates to the nucleus to bind to transcription factors such as Mastermind-like proteins (MAMLs) and CSL for the activation of target transcription genes [62].
Figure 4
Figure 4
Summary of the inflammatory feedback mechanism in the initiation of atherosclerosis. Atherosclerosis is not just a collection of individual events but a positive feedback loop in which each step upregulates the previous one. The infiltration of LDLs into the tunica intima and the creation of lipid-rich macrophages in conjunction with inflammatory cytokines stimulate the progression of atherosclerosis.

References

    1. Fan J., Watanabe T. Atherosclerosis: Known and Unknown. Pathol. Int. 2022;72:151–160. doi: 10.1111/pin.13202. - DOI - PubMed
    1. Matsuura E., Atzeni F., Sarzi-Puttini P., Turiel M., Lopez L.R., Nurmohamed M.T. Is Atherosclerosis an Autoimmune Disease? BMC Med. 2014;12:47. doi: 10.1186/1741-7015-12-47. - DOI - PMC - PubMed
    1. Glovaci D., Fan W., Wong N.D. Epidemiology of Diabetes Mellitus and Cardiovascular Disease. Curr. Cardiol. Rep. 2019;21:21. doi: 10.1007/s11886-019-1107-y. - DOI - PubMed
    1. Citrin K.M., Fernández-Hernando C., Suárez Y. MicroRNA Regulation of Cholesterol Metabolism. Ann. N. Y. Acad. Sci. 2021;1495:55–77. doi: 10.1111/nyas.14566. - DOI - PMC - PubMed
    1. Sarzani R., Spannella F., Di Pentima C., Giulietti F., Landolfo M., Allevi M. Molecular Therapies in Cardiovascular Diseases: Small Interfering RNA in Atherosclerosis, Heart Failure, and Hypertension. Int. J. Mol. Sci. 2023;25:328. doi: 10.3390/ijms25010328. - DOI - PMC - PubMed

MeSH terms

Substances

LinkOut - more resources